Aesthetic practices sit at the intersection of HIPAA (US), GDPR special-category data (EU/UK) and state-specific corporate practice of medicine rules. A single defensive public reply can trigger an OCR breach investigation independent of the review itself. We file HIPAA-safe, attested-not-disclosed removals against non-patients, wrong-clinic confusion, extortion and named-injector defamation. Billed only after successful removal.
HIPAA-safe (BAA signed) · 24-hour eligibility answer · Independent clinics to 200+ location chains

OCR has fined multiple aesthetic and dental practices for public replies that acknowledged the reviewer as a patient — Elite Dental Associates ($10,000), U. Rochester Medical Center ($3M), Manasa Health Center ($30,000). The review itself is not the risk. The reply is. Our workflow is designed to file removal without a single word that could be construed as PHI.
Standard BAA under HIPAA 45 CFR §164.504(e). Chart cross-check is hashed on your side; we see attestation only. 41% first-pass removal on non-patient filings.
For multi-location groups (Ideal Image, LaserAway, SkinSpirit, Ever/Body), GBP-location cross-reference resolves 69% of wrong-clinic complaints on first filing.
False claims about a named injector ("unlicensed", "not a real nurse") contradicted by state board of nursing / medical board / DEA public records reach 72% removal within 4 weeks.
Sources: HIPAA Privacy Rule 45 CFR §164.502 & §164.504(e); OCR Right of Access guidance; AmSpa best-practice guidance 2024; state boards of nursing and medical boards public registers.
Every accepted case maps to one of these six patterns. Reviews that do not match any pattern are declined in writing before any invoice is raised.
| Pattern | HIPAA-safe evidence and typical outcome |
|---|---|
| Reviewer was never a patient (no chart in EHR/PM) | No matching chart in Aesthetic Record, Nextech, PatientNow, Symplast, Boulevard, Zenoti or Mindbody. Attested by medical director under HIPAA-safe protocol. First-pass removal on our 2025-26 med spa log: 41%. |
| Wrong-clinic confusion (same brand, different location) | Extremely common with multi-location groups (Ideal Image, LaserAway, SkinSpirit, Ever/Body, SEV). GBP location cross-reference dispositive. Removal rate 69%. |
| Off-topic: complaint about a different provider or unlicensed injector | Reviewer received treatment elsewhere (a house-party injector, a competitor, or an out-of-state travel clinic) and posted to the wrong profile. Google off-topic rule applies. |
| Result-based defamation misrepresenting the treatment | "They botched my lips" on a patient who received a completely different treatment, or on a documented pre-treatment consent that outlined the exact expected outcome. Consent-signature timeline (not medical content) removes ambiguity — HIPAA-safe. |
| Extortion for a free treatment or refund | Screenshots of patient DMs, front-desk email or text demanding a free syringe, laser package or refund in exchange for taking down the review. Google Prohibited & Restricted Content policy explicit prohibition; near-100% removal when documented. |
| Named-injector defamation ("unlicensed", "not a real nurse") | False claims about a named nurse injector, PA, NP or supervising physician contradicted by state board of nursing / medical board / DEA registration public records. Removal rate 72% within 4 weeks. |
The aesthetics queue applies Google's six global policy categories plus the HIPAA-safe overlay. Filings that acknowledge patient status trigger OCR exposure independent of the review.
No black-box promises. HIPAA-safe at every step, verifiable from your own Google Business Profile dashboard, every fee triggered after removal.
You send review URLs and, if you consent, a hashed chart-check against Aesthetic Record, Nextech, PatientNow, Symplast, Boulevard or Zenoti. We NEVER see PHI. Standard BAA under HIPAA 45 CFR §164.504(e). GDPR art. 28 DPA for EU clinics. Aligned with AmSpa best-practice guidance.
The medical director attests under penalty of perjury that the reviewer has no chart. Google accepts the attestation; you never transmit PHI. First-pass removal on non-patient attestations: 41% in our 2025-26 med spa log.
For multi-location groups, we build a GBP-location evidence pack that shows the reviewer's timestamp/geo doesn't match the flagged property. Off-topic filings for house-party injector complaints follow the same structure — Google's Trust & Safety queue removes these consistently.
When a review falsely claims a named nurse injector is "unlicensed" or "not a real nurse", we escalate under US state defamation + FTC 16 CFR §465, cross-referenced with state board of nursing, medical board and DEA public registers. Removal rate 72% within 4 weeks.
Live-link screenshot from your own Google Business Profile dashboard. $449 (or local equivalent) per removed review, billed only after removal is confirmed. HIPAA obligations maintained throughout. If we fail, you pay nothing.
A weak filing against a real patient erodes your removal-rate baseline for months, can trigger a GBP suspension, and — worst of all — a public reply that identifies the reviewer as a patient is a HIPAA breach even if the review is fake.
Aesthetics is subjective. Honest 1-star reviews from real patients are protected commercial speech. A HIPAA-safe reply plus a service-recovery consult is the right move.
That reply is a HIPAA breach and any removal filing highlights it. We may still remove the review, but the OCR risk is now separate from the review.
Opinion is protected. Removal requires a false statement of fact or a policy violation — not a service judgement.
If your Groupon or website advertised $12/unit and the reviewer paid $12/unit, a "too expensive" review is protected. Fix the merchandising, not the review.
No advance, no attempt fee, no monthly minimum. Local currency equivalents apply (£359 UK, €449 EU, C$599 Canada, A$649 Australia, ₹19,999 India, R$2,499 Brazil), plus VAT/GST where applicable. Volume pricing from 30 reviews per quarter for multi-location groups. If we take a case and fail, you pay nothing.
Sibling pages and background reading from the BGR Review team.